Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-25T15:30:01.687Z Has data issue: false hasContentIssue false

Myasthenia Gravis and the HL-A System

Published online by Cambridge University Press:  01 August 2014

Ella van den Berg-Loonen*
Affiliation:
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands
C.P. Engelfriet
Affiliation:
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands
T.E.W. Feltkamp
Affiliation:
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands
L.E. Nijenhuis
Affiliation:
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands
H.J.G.H. Oosterhuis
Affiliation:
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands
A.L. van Rossum
Affiliation:
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands
J.J. van Loghem
Affiliation:
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands
*
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, P.O.B. 9190, Amsterdam, The Netherlands

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

On the basis of a research on 100 patients a correlation is shown to exist between myasthenia gravis and HL-A 8.

The findings further support the supposition that myasthenia gravis should be divided into two types, respectively showing an increase of HL-A 8 and an increase of HL-A 2.

Type
6. Free Contributions: Second Group
Copyright
Copyright © The International Society for Twin Studies 1974

References

REFERENCES

Berg-Loonen, E. van den, Engelfriet, C.P., Feltkamp, T.E.W., Nijenhuis, L.E., Galama, J.M.D., Rijn, A.C.M. van, Verheught, F.W.H., Kort-Bakker, M., Loghem, J.J. van. Myasthenia gravis and the HL-A system. (In preparation).Google Scholar
Dausset, J. 1972. Correlation Between Histocompatibility Antigens and Susceptibility to Illness. In Schwartz, R.S. (ed.): Progress in Clinical Immunology. [Vol. I, p. 183]. New York: Grune & Stratton.Google Scholar
Feltkamp, T.E.W., Berg-Loonen, E. van den, Nijenhuis, L.E., Oosterhuis, H.J.G.H., Engelfriet, C.P., Rossum, A.L. van, Laghem, J.J. van 1974. Myasthenia gravis, autoantibodies and HL-A antigens. Br. Med. J., 1: 131133.CrossRefGoogle ScholarPubMed
McKay, I.R., Morris, P.J. 1972. Association of autoimmune active chronic hepatitis with HL-A 1, 8. Lancet, 2: 793.CrossRefGoogle Scholar
McNeish, A.S., Nelson, R., Mackintosh, P. 1973. HL-A 1 and 8 in childhood coeliac disease. Lancet, 1: 668.Google Scholar
Pirskanen, R., Tiilikainen, A., Hokkanen, E. 1972. Histocompatibility (HL-A) antigens associated with myasthenia gravis. Ann. Clin. Res., 4: 304.Google ScholarPubMed
Stokes, P.L., Asquith, P., Holmes, G.K.T., Mackintosh, P., Cooke, W.T. 1972. Histocompatibility antigens associated with adult coeliac disease. Lancet, 2: 162.Google Scholar
White, A.G., Barnetson, R.St.C., Da Costa, J.A.G., McClelland, D.B.R. 1973. HL-A and disordered immunity. Lancet, 1:108.Google Scholar